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Available online 29 September 2016Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) is an advancedmethod used
globally to analyze the distribution of biomolecules on tissue cryosections without any probes. In bones, however,
hydroxyapatite crystals make it difficult to determine the distribution of biomolecules using MALDI-IMS. Addition-
ally, there is limited information regarding the use of this method to analyze bone tissues. To determine whether
MALDI-IMS analysis of bone tissues can facilitate comprehensive mapping of biomolecules in mouse bone, we
first dissected femurs and tibiae from 8-week-old male mice and characterized the quality of multiple fixation
and decalcificationmethods for preparation of the samples. Cryosectionsweremounted on indium tin oxide-coated
glass slides, dried, and then a matrix solution was sprayed on the tissue surface. Images were acquired using an
iMScope at a mass-to-charge range of 100–1000. Hematoxylin-eosin, Alcian blue, Azan, and periodic acid-Schiff
staining of adjacent sections was used to evaluate histological and histochemical features. Among the various fixa-
tion and decalcification conditions, sections from trichloroacetic acid-treated samples were most suitable to exam-
ine both histology and comprehensive MS images. However, histotypic MS signals were detected in all sections. In
addition to theMS images, phosphocholinewas identified as a candidatemetabolite. These results indicate success-
ful detection of biomolecules in bone using MALDI-IMS. Although analytical procedures and compositional adjust-
ment regarding the performance of the device still require further development, IMS appears to be a powerful
tool to determine the distribution of biomolecules in bone tissues.








Recent advances in omics approaches allow for the identification of
whole molecules constituting an organism, which can provide insight
into pathogenic processes and serve as biomarker candidates. Informa-
tion obtained from omics research, such as proteomics and metabolo-
mics, has become particularly important for elucidating etiology and
for diagnosis of diseases. However, conventional imaging techniques,
such as immunohistochemistry, require labeling and have limited use
for revealing new pathological molecules in tissue.
Mass spectrometry (MS) is a commonly used technology to detect
analytes in proteomics andmetabolomics research, and can directly de-
fine individual molecular species in complex samples. Among MS
methods, matrix-assisted laser desorption/ionization-imaging mass
spectrometry (MALDI-IMS) enables analysis of the molecule distribu-
tion without any disruption of the morphology or architecture. Ind Tissue Biology, Hiroshima
, 1-2-3, Kasumi, Minami-ku,
ally to this work.
. This is an open access article undercontrast, liquid chromatography-MS or gas chromatography-MS analy-
ses require the use of tissue homogenates, which retains no tissue local-
ization information.
Although cellular and molecular analyses are useful for many types
of tissues, they are difficult to use with calcified tissues such as bones
and teeth. This limits investigation of the function of cells such as oste-
ocytes and cementocytes, or the distribution of organic matter such as
proteins and peptides. For example, osteocytes, which terminally differ-
entiate from osteoblasts and are embedded in the bone matrix, play an
important role in the maintenance of homeostasis in the network be-
tween osteoblasts and osteoclasts (Bonewald, 2011). To examine the
physiological functions of osteocytes, it is preferable to retain the origi-
nal distribution of biomolecules. However, MALDI-IMS has certain lim-
itations for quantitative and qualitative uncertainty analyses.
Additionally, there are few studies that have applied MALDI-IMS to
bone tissues to identify molecules because of the lack of appropriate
methods to prepare sections for ionization (Hirano et al., 2014;
Cillero-Pastor et al., 2015; Seeley et al., 2014). Hirano et al. (Hirano et
al., 2014) reported MALDI-IMS for tooth cryosections prepared by the
Kawamoto method using adhesive film without any pretreatment,
such as fixation or decalcification. However, the signals obtained from
the enamel and dentin were not listed in the metabolomics database.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Combinations of fixation and decalcification solutions.
A B C D E F G H
Fixation – TCA, overnight PFA, overnight Carnoy, overnight PFA, overnight Carnoy, overnight – –
Decalcification – EDTA, 7 days EDTA, 7 days Formic acid, 2 days Formic acid, 2 days Formic acid, 2 days EDTA, 4 days
Fig. 1. Histological observations of femurs and tibiae fixed and decalcified with each
solution by hematoxylin-eosin (H-E), Alcian blue, Azan, and Periodic Acid-Schiff (PAS)
staining. (A) Sections of unfixed/undecalcified tibiae. (B) Sections of trichloroacetic acid
(TCA)-treated femurs. (C–H) Sections of femurs treated with 4% paraformaldehyde
(PFA)/EDTA (C), Carnoy/EDTA (D), PFA/formic acid (E), or Carnoy/formic acid (F). (G,
H), Unfixed sections of femurs decalcified with formic acid (G) or EDTA (H).
Representative images are shown; n = 2–5.
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interrupt ionization of large components.
Therefore, in this studywe established a protocol to fix and decalcify
samples derived from bone to detect MS using MALDI-IMS and provide
a comprehensive map of proteins and peptides.
2. Materials and methods
2.1. Materials
Conductive indium tin oxide (ITO)-coated glass slides (8–12 Ω)
were purchased from Sigma-Aldrich Co. (St. Louis, MO). α-Cyano-4-
hydroxycinnamic acid (CHCA) matrices were purchased from Bruker
Daltonics (Bremen, Germany). Carboxymethylcellulose (CMC; 2%) was
purchased from Leica Microsystems (Wetzlar, Germany).
Trifluoroacetic acid (TFA), 2,5-dihydroxy-benzoic acid (DHB), and all
other chemicals, unless specified otherwise, were purchased from
Sigma-Aldrich Co.
2.2. Animals
C57BL/6J mice were purchased from CLEA Inc. (Osaka, Japan). The
mice were housed and handled to minimize pain and discomfort ac-
cording to protocols approved by the Institutional Animal Care and
Use Committee at the Central Institute for Experimental Animals and
the Committee of Animal Experimentation at Hiroshima University.
2.3. Specimen preparation
Femurs and/or tibiae from 8-week-old male mice were fixed and
decalcified in various combinations of fixatives [4% paraformaldehyde
(PFA), Carnoy fluid or trichloroacetic acid (TCA)] and decalcification so-
lutions (formic acid, EDTA-NH4, or TCA) (Table 1). Fresh samples, with
or without decalcification, were also prepared. The samples were then
embedded in a stainless steel container filled with 2% CMC and placed
in dry ice-cooled hexane to prepare frozen CMC blocks. Each frozen
block was stored at −80 °C until sectioning. Tissues were sectioned
(5 μm for staining and MALDI-IMS of fresh samples without any pre-
treatment by the Kawamoto method (Kawamoto, 2003), and 10 μm
for MALDI-IMS of samples with pretreatment) with a CM 3050 S cryo-
stat (LeicaMicrosystems). For staining, the sectionswere placed on nor-
mal glass slides and washed with 100% ethanol. For MALDI-IMS, the
sections were placed on ITO-coated glass slides with electrically
conducting double-adhesive tape for samples without pretreatment,
followed by washing with 70% and then 100% ethanol, and dried.
2.4. Staining
Adjacent sections were stained with hematoxylin-eosin (H-E),
Alcian blue, Azan, and Periodic Acid-Schiff (PAS) to evaluate histological
and histochemical features. Sections that did not undergo previous fix-
ation were fixed with 4% PFA before staining.
2.5. MALDI-IMS and MS-MS
After drying at room temperature, cryosections were coated with a
DHB or CHCAmatrix vapor deposition using an iMlayer (Shimadzu Cor-
poration, Kyoto, Japan) at a thickness of 1.5 or 0.7 μm, respectively.
MALDI images were acquired using an iMScope (ShimadzuCorporation) in positive or negative ion modes in the mass-to-charge
ratio (m/z) range of 100–1000, at a laser frequency of 1000 Hz,
282 Y. Fujino et al. / Bone Reports 5 (2016) 280–285accumulating 50 laser shots. Detector and sample voltages were 1.7–
1.9 kV and 3–3.5 kV, respectively. Spatial resolution was 10 μm and
laser intensity ranged from23 to 45. To prevent any influence offixation
and decalcification solutions as well as matrices, 1 μL of each solution
and matrix was placed onto a stainless steel plate and applied to the
iMScope after drying. Mass spectra obtained from this mixture were
omitted from spectra of the samples. Principal component analysis
(PCA) was used to extract the peak matrix from the mass spectrum
and search for principal components as characteristic patterns in the
images (Shao et al., 2012).
To identify the metabolites in bones, the TCA-treated sections from
mouse femurs were applied to iMScope in positive ion mode with the
DHBmatrix.MS-MS datawere evaluated using theHumanMetabolomeFig. 2. Mass spectra (maximum intensity) and MALDI-IMS analysis of TCA-treated samples in
benzoic acid (DHB) or α-cyano-4-hydroxycinnamic acid (CHCA) matrix in positive or negativ
several mass peaks from the sections. Left panels show optical images and H-E staining. (C) M
Representative images and data are shown. n N 3.Database search engine (version 3.6, TheMetabolomics Innovaton Cen-
tre, Edmonton, Canada) for metabolite identification.
Phosphocholine inferred by MS-MS data was mixed with DHB and
applied to the iMScope. The MS-MS spectrum was compared with that
detected in sections.
3. Results
3.1. Histological and histochemical features of bones with or without
pretreatment
To evaluate the influence of fixation and decalcification solutions on
the histological and histochemical features of femurs and tibiae,the range ofm/z 100–1000 under various conditions. (A) Analysis with a 2,5-dihydroxy-
e ion modes in the range of m/z 100–1000. (B) Imaging of the histotypic distribution of
ass spectra detected in sections with or without cryofilm in the range of m/z 100–1000.
283Y. Fujino et al. / Bone Reports 5 (2016) 280–285cryosections were stained with H-E, Alcian blue, Azan, and PAS. Among
the various fixation and decalcification conditions, sections from TCA-
treated samples were the most suitable to examine both histology and
comprehensive MS images (Fig. 1B), followed by samples decalcified
with EDTA after fixation (Fig. 1C, D). Bone marrow peeled from trabec-
ular bone surfaces in samples decalcified with formic acid (Fig. 1E, F).
Cartilage in the growth plate and bone marrow were unable to keep
their structure in decalcified samples without fixation (Fig. 1G, H).
There was no difference between samples with Azan or PAS staining.
However, with Alcian Blue staining, bone marrow in unfixed and
Carnoy/EDTA-treated samples turned dark blue (Fig. 1A, D, G, and H).
3.2. Comparison of MALDI-IMS between bones with or without
pretreatment
In MALDI-IMS analysis, an appropriate matrix is required to obtain
successful images (Setou and Kurabe, 2011). To establish the measure-
ment conditions ofMALDI-IMS, all sampleswere applied to the iMScope
in positive or negative ion modes with DHB or CHCA matrices. Among
these conditions, the positive mode with DHB enabled detection of
many mass spectra in a wide range of m/z (Fig. 2A, samples treatedFig. 3. Mass spectra (maximum intensity) of each treatment with MALDI-IMS in the range of
femurs treated with TCA, PFA/EDTA, Carnoy/EDTA, PFA/formic acid, or Carnoy/formic ac
Representative data are shown. n N 3.with TCA). Imaging by MALDI-IMS showed tissue-specific distribution
of MS with DHB (Fig. 2B). Because the Kawamoto method requires
cryofilm, MALDI-IMS of TCA-treated sections mounted on ITO-coated
glass slides with or without cryofilm were analyzed to measure the in-
terference of cryofilm. With cryofilm, the number of mass spectra was
much less than without cryofilm (Fig. 2C).
A comparison of mass spectra detected in positive ion mode with
DHB showed that the undecalcified sample with the Kawamoto
method exhibited few peaks in the range of m/z 100–700 (Fig. 3).
Each section had its own characteristic features of the appearance
of peaks, but there was no significant difference in the obtained
number of mass spectra between samples that were decalcified,
fixed, or both (Fig. 3).
In MALDI-IMS, histotypic MS signals were detected in all sections.
The signals of the molecule at m/z 554.57 were located mainly in bone
marrow in all sections except undecalcified sections. The molecule at
m/z 185.13 was located mainly in cortical bones, trabecular bones, and
cartilage in all sections except the Carnoy/formic acid sample (Fig. 4).
In the undecalcified section, there were a few signals at m/z 554.57,
and the signals at m/z 185.13 were localized diffusely in the Carnoy/
formic acid sample (Fig. 4).100–1000 and the positive ion mode with DHB. Sections of unfixed/undecalcified tibiae,
id, and femurs decalcified with formic acid or EDTA in the range of m/z 100–1000.
Fig. 4. MALDI-IMS at m/z 554.57 and m/z 185.13 of each treatment. Optical images (upper). MALDI-IMS at m/z 554.57 (middle) and at m/z 185.13 (lower) with indicated treatment.
Representative images and data are shown. n N 3.
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variance between samples, revealed that the first principal component
was the same in samples except undecalcified, Carnoy/EDTA, and PFA/
formic acid samples in the range of m/z 100–700 (Table 2).
3.3. Metabolomics of mouse femurs
To identifymetabolites in bone, TCA-treated sections frommouse fe-
murs were applied to the iMScope in positive ion mode with the DHB
matrix. Several MS-MS data sets were subjected to the humanmetabo-
lome database, and some high-scoring candidates were recovered. Of
these, the molecule at m/z 184.07 was identified as phosphocholine
(Fig. 5B). For confirmation, an authentic sample of phosphocholine
was applied to the iMScope. The MS-MS spectra were in agreement
with those obtained from the tissue sections (Fig. 5C).
4. Discussion
In this study, we comprehensively determined the metabolomics of
mouse bones with localization information using MALDI-IMS. We also
characterized different fixation and decalcification techniques and
established an effective method for preparation of mouse bone tissue.
When preparing cryosections of hard tissueswithout decalcification,
the Kawamoto method requires cryofilm that can attach to the cutting
surface under freezing conditions (Kawamoto, 2003). Furthermore, for
ionization, an electrically conducting double-adhesive tape is needed
to affix sections on the ITO-glass slide (Hirano et al., 2014). Comparison
of mass spectra between sections with or without tape revealed that
manymore peakswere obtained from the sectionwithout tape. Ameth-
od has been reported to remove the tape before application to MALDI-
IMS (Seeley et al., 2014), but a high degree of technical skill is required
to do so.
For MALDI-IMS, fresh frozen sections (without fixation) are usually
used for analysis. This study showed that fixation and decalcification
of bones facilitates the preparation of sections, and detection of MS
from organic components is possible because of mineral removal. Be-
cause the utility of MALDI-IMS has been reported for formalin-fixed,Table 2
First principal component with or without pretreatment.
Unfixed/undecalcified TCA PFA/EDTA Carnoy/EDTA
m/z 100–400 165.07 114.91 114.91 114.91
m/z 400–700 456.11 462.73 462.73 412.71paraffin-embedded (FFPE) tissues (Lemaire et al., 2007), researchers
have focused on analysis of FFPE samples by MALDI-IMS (Ronci et al.,
2008; Djidja et al., 2009; Stauber et al., 2010; Cole et al., 2013; Powers
et al., 2014; Gravius et al., 2015; O'Rourke et al., 2015). Formalin fixation
can be used to avoid degradation and spoilage of samples. However, the
cross-linked molecules between formalin and primary amines are un-
able to be ionized. Therefore, the number of identified proteins in FFPE
sections is less than that in cryosections, and several steps are required
to remove formalin, break crosslinks, and cleave proteins to peptides
(Ronci et al., 2008; O'Rourke et al., 2015; Fowler et al., 2013). For re-
search targeting nucleotides, lipids, or peptides without primary
amines, of which formalin does not form crosslinks, it is possible to
apply the samples without such steps. Organic solvents such as ethanol
can also fix tissues by coagulation and precipitation of proteins. Fixation
with organic solvents has less impact onMALDI-IMS analysis, but it dis-
solves lipids from tissues. Some of thefirst principal components detect-
ed by PCAwere the same among the samples, but somewere not. These
findings suggest that researchers should select a fixation solution ac-
cording to the object used for analysis. The selection of the appropriate
matrix is also crucial; DHB and CHCA are suitable for imaging small or-
ganic compounds, such as lipids and peptides, respectively (Setou and
Kurabe, 2011).
Decalcification with EDTA or TCA was better than with formic acid
formaintaining the tissue structures. Bonemarrowhad peeled from tra-
becular bone surfaces using formic acid decalcification, which can occur
during the preparation of sections (Prasad and Donoghue, 2013). Treat-
ment with TCA is useful because of rapid one-step fixation and decalci-
fication that can preserve antigens and tissue morphology (Athanasou
et al., 1987). In this study, sections from TCA-treated samples were the
most suitable to examine both histology and comprehensive MS
images.
By performing metabolomics of TCA-treated samples from mouse
bonewithMALDI-IMS, wewere able to identify biomolecules, including
phosphocholine, an important biomolecule for bone mineralization
(Roberts et al., 2007; Yadav et al., 2011; Stewart et al., 2006; Kvam et
al., 1992; Stern and Vance, 1987). Phosphocholine can be cleaved by
PHOSPHO1, a soluble phosphatase that is responsible for initiatingPFA/formic acid Carnoy/formic acid Unfixed/formic acid Unfixed/EDTA
184.08 114.91 114.91 114.91
462.73 462.73 462.73 462.73
Fig. 5.MS-MS data atm/z 184.07 in sections and an authentic sample of phosphocholine.
(A) An optical image (left), H-E staining (middle), andMS image atm/z 184.07 (right). (B)
MS-MS spectra of an authentic sample of phosphocholine. (C) Product ions predicted a
part of the structure as indicated by the arrow. n = 3.
285Y. Fujino et al. / Bone Reports 5 (2016) 280–285hydroxyapatite crystal formation inside osteoblast-derivedmatrix vesi-
cles (Roberts et al., 2007; Stewart et al., 2006). PHOSPHO1-R74X null
mutant mice display skeletal and growth plate abnormalities and a de-
crease in growth rate (Yadav et al., 2011). Phosphocholine is one of the
abundant phosphomonoesters in cartilage (Kvam et al., 1992), and low
accumulation of phosphocholine in calvarial tissue comparedwith liver
is consistent with the upregulation of PHOSPHO1 activity in calvaria,
whose function reduces the levels of phosphocholine in chondrocytes
and osteoblasts (Stern and Vance, 1987).
This study successfully detected biomolecules in bones using
MALDI-IMS. Although analytical procedures and compositional adjust-
ment on device performance require further development, MALDI-IMS
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